- O O O O
Bedoelde O O O O
u O O O O
[dans](/nl/search/biblio/dans) O O O O
Zoekresultaten O O O O
- O O O O
448 O O O O
results O O O O
[Automatic O O O O
detection O O O O
of O O O O
airborne O O O O
pollen: O O O O
an O O O O
overview](https://www.sciensano.be/nl/biblio/automatic-detection-airborne-pollen-overview) O O O O
available O O O O
with O O O O
a O O O O
delay O O O O
of O O O O
3-9 O O O O
days O O O O
and O O O O
usually O O O O
delivered O O O O
at O O O O
a O O O O
daily O O O O
resolution. O O O O
Several O O O O
automatic O O O O
instruments O O O O
have O O O O
come O O O O
on O O O O
to O O O O
the O O O O
market O O O O
over O O O O
the O O O O
past O O O O
few O O O O
years, O O O O
with O O O O
more O O O O
new O O O O
devices O O O O
also O O O O
under O O O O
development. O O O O
... O O O O
[Direct O O O O
impact O O O O
of O O O O
COVID-19 O O O O
by O O O O
estimating O O O O
disability-adjusted O O O O
life O O O O
years O O O O
at O O O O
national O O O O
level O O O O
in O O O O
France O O O O
in O O O O
2020](https://www.sciensano.be/nl/biblio/direct-impact-covid-19-estimating-disability-adjusted-life-years-national-level-france-2020) O O O O
[https://www.sciensano.be/nl/biblio/direct-impact-covid-19-estimating-disability-adjusted-life-years-national-level-france-2020](https://www.sciensano.be/nl/biblio/direct-impact-covid-19-estimating-disability-adjusted-life-years-national-level-france-2020) O O O O
post-acute O O O O
consequences, O O O O
in O O O O
28 O O O O
days O O O O
(baseline) O O O O
up O O O O
to O O O O
140 O O O O
days, O O O O
following O O O O
the O O O O
initial O O O O
infection. O O O O
METHODS: O O O O
National O O O O
mortality, O O O O
COVID-19 O O O O
screening, O O O O
and O O O O
hospital O O O O
admission O O O O
data O O O O
were O O O O
used O O O O
to O O O O
calculate O O O O
DALY O O O O
s O O O O
based O O O O
... O O O O
[COVID-19 Reason 5 O O
vaccine Reason 5 O O
effectiveness Reason 5 O O
against Reason 5 O O
symptomatic Reason 5 O O
infection Reason 5 O O
and Reason 5 O O
hospitalisation Reason 5 O O
in Reason 5 O O
Belgium, Reason 5 O O
July Reason 5 O O
2021 Reason 5 O O
to Reason 5 O O
May Reason 5 O O
2022.](https://www.sciensano.be/nl/biblio/covid-19-vaccine-effectiveness-against-symptomatic-infection-and-hospitalisation-belgium-july-2021) Reason 5 O O
[https://www.sciensano.be/nl/biblio/covid-19-vaccine-effectiveness-against-symptomatic-infection-and-hospitalisation-belgium-july-2021](https://www.sciensano.be/nl/biblio/covid-19-vaccine-effectiveness-against-symptomatic-infection-and-hospitalisation-belgium-july-2021) Reason 5 O O
100-150 Reason 5 O O
days Reason 5 O O
after Reason 5 O O
the Reason 5 O O
primary Reason 5 O O
vaccination Reason 5 O O
course. Reason 5 O O
Booster Reason 5 O O
vaccination Reason 5 O O
increased Reason 5 O O
initial Reason 5 O O
VE Reason 5 O O
i Reason 5 O O
to Reason 5 O O
85% Reason 5 O O
(95% Reason 5 O O
CI: Reason 5 O O
84-85). Reason 5 O O
Against O O O O
Antibody O O O O
Detection O O O O
in O O O O
Wild O O O O
Boar O O O O
and O O O O
Sheep: O O O O
Impact O O O O
of O O O O
the O O O O
Screening O O O O
Approach O O O O
on O O O O
the O O O O
Estimated O O O O
Seroprevalence.](https://www.sciensano.be/nl/biblio/comparison-serological-methods-tick-borne-encephalitis-virus-specific-antibody-detection-wild-boar-0) O O O O
[https://www.sciensano.be/nl/biblio/comparison-serological-methods-tick-borne-encephalitis-virus-specific-antibody-detection-wild-boar-0](https://www.sciensano.be/nl/biblio/comparison-serological-methods-tick-borne-encephalitis-virus-specific-antibody-detection-wild-boar-0) O O O O
18 O O O O
days O O O O
post-infection, O O O O
the O O O O
ELISA O O O O
s O O O O
classified O O O O
only O O O O
50% O O O O
and O O O O
31% O O O O
of O O O O
the O O O O
samples O O O O
as O O O O
positive. O O O O
Both O O O O
routinely O O O O
used O O O O
ELISA O O O O
s O O O O
for O O O O
TBEV O O O O
antibody O O O O
screening O O O O
in O O O O
animal O O O O
sera O O O O
were O O O O
shown O O O O
to O O O O
have O O O O
a O O O O
low O O O O
sensitivity, O O O O
... O O O O
[Daily O O O O
allergy O O O O
burden O O O O
and O O O O
heart O O O O
rate O O O O
characteristics O O O O
in O O O O
adults O O O O
with O O O O
allergic O O O O
rhinitis O O O O
based O O O O
on O O O O
a O O O O
wearable O O O O
telemonitoring O O O O
system](https://www.sciensano.be/nl/biblio/daily-allergy-burden-and-heart-rate-characteristics-adults-allergic-rhinitis-based-a-wearable) O O O O
[https://www.sciensano.be/nl/biblio/daily-allergy-burden-and-heart-rate-characteristics-adults-allergic-rhinitis-based-a-wearable](https://www.sciensano.be/nl/biblio/daily-allergy-burden-and-heart-rate-characteristics-adults-allergic-rhinitis-based-a-wearable) O O O O
participant-days O O O O
of O O O O
72 O O O O
participants. O O O O
A O O O O
one-point O O O O
increase O O O O
in O O O O
allergy O O O O
symptom O O O O
score O O O O
was O O O O
associated O O O O
with O O O O
an O O O O
increase O O O O
in O O O O
next-day O O O O
resting O O O O
heart O O O O
rate O O O O
of O O O O
0.08 O O O O
(95% O O O O
CI: O O O O
0.02-0.15) O O O O
beats O O O O
per O O O O
minute. O O O O
A O O O O
one-point O O O O
increase O O O O
... O O O O
[The O O O O
contribution O O O O
of O O O O
cacao O O O O
consumption O O O O
to O O O O
the O O O O
bioaccessible O O O O
dietary O O O O
cadmium O O O O
exposure O O O O
in O O O O
the O O O O
Belgian O O O O
population](https://www.sciensano.be/nl/biblio/contribution-cacao-consumption-bioaccessible-dietary-cadmium-exposure-belgian-population) O O O O
[https://www.sciensano.be/nl/biblio/contribution-cacao-consumption-bioaccessible-dietary-cadmium-exposure-belgian-population](https://www.sciensano.be/nl/biblio/contribution-cacao-consumption-bioaccessible-dietary-cadmium-exposure-belgian-population) O O O O
the O O O O
Belgian O O O O
population, O O O O
in O O O O
combination O O O O
with O O O O
ICP- O O O O
MS O O O O
analysis O O O O
of O O O O
a O O O O
large O O O O
subset O O O O
of O O O O
cacao-containing O O O O
products O O O O
(N=349). O O O O
Both O O O O
the O O O O
average O O O O
chocolate O O O O
consumption O O O O
(28 O O O O
g O O O O
day-1) O O O O
and O O O O
the O O O O
relative O O O O
contribution O O O O
of O O O O
... O O O O
[Forecasting O O O O
Birch O O O O
Pollen O O O O
Levels O O O O
in O O O O
Belgium: O O O O
First O O O O
Analysis O O O O
of O O O O
the O O O O
2021 O O O O
Season](https://www.sciensano.be/nl/biblio/forecasting-birch-pollen-levels-belgium-first-analysis-2021-season) O O O O
[https://www.sciensano.be/nl/biblio/forecasting-birch-pollen-levels-belgium-first-analysis-2021-season](https://www.sciensano.be/nl/biblio/forecasting-birch-pollen-levels-belgium-first-analysis-2021-season) O O O O
Transport O O O O
Models O O O O
(CTM O O O O
's) O O O O
are O O O O
able O O O O
to O O O O
quantify O O O O
the O O O O
spatial O O O O
and O O O O
temporal O O O O
distributions O O O O
of O O O O
airborne O O O O
birch O O O O
pollen O O O O
levels O O O O
a O O O O
few O O O O
days O O O O
ahead. O O O O
Recently, O O O O
a O O O O
new O O O O
dataset O O O O
on O O O O
the O O O O
birch O O O O
pollen O O O O
emission O O O O
sources O O O O
has O O O O
been O O O O
... O O O O
[Aluminium O O O O
intake O O O O
through O O O O
the O O O O
consumption O O O O
of O O O O
selected O O O O
baby O O O O
foods O O O O
and O O O O
risk O O O O
characterization O O O O
in O O O O
a O O O O
population O O O O
of O O O O
Brazilian O O O O
infants O O O O
aged O O O O
0 O O O O
to O O O O
36 O O O O
months](https://www.sciensano.be/nl/biblio/aluminium-intake-through-consumption-selected-baby-foods-and-risk-characterization-a-population) O O O O
[https://www.sciensano.be/nl/biblio/aluminium-intake-through-consumption-selected-baby-foods-and-risk-characterization-a-population](https://www.sciensano.be/nl/biblio/aluminium-intake-through-consumption-selected-baby-foods-and-risk-characterization-a-population) O O O O
frequency O O O O
and O O O O
daily O O O O
food O O O O
consumption O O O O
(in O O O O
g/day) O O O O
were O O O O
observed O O O O
for O O O O
infant O O O O
formulas O O O O
and O O O O
meat/vegetable O O O O
purees, O O O O
respectively. O O O O
Boys O O O O
presented O O O O
higher O O O O
frequency O O O O
consumption O O O O
of O O O O
infant O O O O
formulas, O O O O
while O O O O
meat/vegetable O O O O
... O O O O
[Microbiological O O O O
safety O O O O
of O O O O
aged O O O O
meat.](https://www.sciensano.be/nl/biblio/microbiological-safety-aged-meat) O O O O
prevented O O O O
by O O O O
ensuring O O O O
a O O O O
meat O O O O
surface O O O O
temperature O O O O
of-0.5 O O O O
to O O O O
3.0Â°C, O O O O
with O O O O
a O O O O
relative O O O O
humidity O O O O
(RH) O O O O
of O O O O
75-85% O O O O
and O O O O
an O O O O
airflow O O O O
of O O O O
0.2-0.5 O O O O
m/s O O O O
for O O O O
up O O O O
to O O O O
35 O O O O
days. O O O O
The O O O O
main O O O O
meat O O O O
include O O O O
spp, O O O O
spp. O O O O
... O O O O
treatment O O O O
on O O O O
outcome O O O O
of O O O O
hospitalised O O O O
influenza O O O O
patients, O O O O
surveillance O O O O
data O O O O
from O O O O
11 O O O O
EU O O O O
countries, O O O O
2010 O O O O
to O O O O
2020.](https://www.sciensano.be/nl/biblio/effect-neuraminidase-inhibitor-oseltamivir-treatment-outcome-hospitalised-influenza-patients) O O O O
[https://www.sciensano.be/nl/biblio/effect-neuraminidase-inhibitor-oseltamivir-treatment-outcome-hospitalised-influenza-patients](https://www.sciensano.be/nl/biblio/effect-neuraminidase-inhibitor-oseltamivir-treatment-outcome-hospitalised-influenza-patients) O O O O
decreased O O O O
risk O O O O
(aOR O O O O
0.91, O O O O
95% O O O O
CI: O O O O
0.90-0.93). O O O O
NAI O O O O
treatment O O O O
initiation O O O O
within O O O O
48 O O O O
hours O O O O
and O O O O
up O O O O
to O O O O
7 O O O O
days O O O O
reduced O O O O
risk O O O O
of O O O O
dying O O O O
(0-48 O O O O
hours O O O O
